跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOXORUBICIN-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
DOXORUBICIN-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML
Approved
THERAPEUTIC
DOXORUBICIN-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML
S.C. SINDAN-PHARMA S.R.L
🇸🇬 Health Sciences Authority
Approval Date
Mar 21, 2016
Approval ID
872d632e72fcba8f
Company
S.C. SINDAN-PHARMA S.R.L
Type
Therapeutic
Approval Details
Approval Id
872d632e72fcba8f
Drug Name
DOXORUBICIN-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML
Product Name
DOXORUBICIN-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML
Approval Number
SIN14969P
Approval Date
2016-03-21
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION, CONCENTRATE
Route Of Administration
INTRAVENOUS, INTRAVESICAL
Atc Code
L01DB01
Atc Item Name
doxorubicin
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Doxorubicin hydrochloride
2mg/ml
DOXORUBICIN HYDROCHLORIDE
2 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 21, 2016
Approval ID
872d632e72fcba8f
Type
Therapeutic
Back to HSA Approvals
